The Pharma Committee, headed by AbbVie CEO and AmCham Board member Raphy Blum, continues to make headway in promoting regulatory changes to advance the Pharma industry's ease of doing business in Israel. The committee recently met again with Mr. Moshe Bar-Simantov the Director-General of the Ministry of Health, who decided to ease several barriers in clinical trials regulations. In this process, the committee is holding additional meetings and round tables with senior officials of the Ministry of Health and other ministries.